Symbol="ACLX"
AssetType="Common Stock"
Name="Arcellx Inc"
Description="Arcellx, Inc., a clinical-stage biotechnology company, is engaged in the development of various immunotherapies for patients with cancer and other incurable diseases. The company is headquartered in Gaithersburg, Maryland."
CIK="1786205"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)"
Address="25 WEST WATKINS MILL ROAD, SUITE A, GAITHERSBURG, MD, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="1650496000"
EBITDA="-194135008"
PERatio="None"
PEGRatio="None"
BookValue="6.35"
DividendPerShare="0"
DividendYield="0"
EPS="-4.55"
RevenuePerShareTTM="0.418"
ProfitMargin="0"
OperatingMarginTTM="-10.92"
ReturnOnAssetsTTM="-0.281"
ReturnOnEquityTTM="-0.715"
RevenueTTM="17912000"
GrossProfitTTM="0"
DilutedEPSTTM="-4.55"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="49.6"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="-"
PriceToBookRatio="6.12"
EVToRevenue="-"
EVToEBITDA="-7.34"
Beta="None"
num_52WeekHigh="48.91"
num_52WeekLow="15.63"
num_50DayMovingAverage="35.72"
num_200DayMovingAverage="31.55"
SharesOutstanding="47993500"
DividendDate="None"
ExDividendDate="None"
symbol="ACLX"
open="34.44"
high="35.28"
low="33.31"
price="34.81"
volume="477950.00"
latest_trading_day="2023-08-08"
previous_close="34.39"
change="0.42"
change_percent="1.2213%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="42"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="58"
Volume_recent_avg="573993"
Change_recent_avg="0.08"
Delta_recent_avg="1.94"
Variance_recent_avg="0.97"
Change_ratio_recent_avg="0.19"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="58"
Aroon_momentum_negative="42"
image_negative_thumbnail_id_1="496"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0109.jpeg"
image_negative_thumbnail_id_2="159"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0017.jpeg"
image_neutral_thumbnail_id_1="533"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0066.jpeg"
image_neutral_thumbnail_id_2="558"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0041.jpeg"
image_positive_thumbnail_id_1="1010"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0172.jpeg"
image_positive_thumbnail_id_2="967"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0129.jpeg"
image_professor_thumbnail_id_1="1181"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0015.jpeg"
image_professor_thumbnail_id_2="1182"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0016.jpeg"
